NovaBiotics Ltd Alternatives & Competitors

12 companies similar to NovaBiotics Ltd — Developing first-in-class solutions for unmet health and personal care needs

Clarametyx Biosciences

Targeting biofilms to treat chronic respiratory disease

23 Series A $54.25M

Columbus, United States

Biotechnology Health Care +1

OCEAN BIOMEDICAL

Empowering great medical science.

12 Post-IPO Debt $36.04M

Providence, United States

Biotechnology Health Care

Armata Pharmaceuticals, Inc.

PURPOSEFUL. PRECISE. POWERFUL.

71 Post-IPO Debt $286.00M

Los Angeles, United State...

Biotechnology Health Care +1

Mediar Therapeutics

Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt...

55 Series A $85.00M

Boston, United States

Biotechnology Health Care +1

Track all NovaBiotics Ltd competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tolerx, Inc.

9 Venture round $145.50M

Cambridge, United States

Biotechnology Health Care

Eloxx Pharmaceuticals

Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...

12 IPO $63.29M

Watertown, United States

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

44 IPO $218.00M

Singapore, Singapore

Biotechnology Health Care +1

Gossamer Bio

Vision * Connection * Innovation

159 Post-IPO Equity $812.00M

San Diego, United States

Biotechnology Health Care +1

Arcturus Therapeutics

A messenger RNA medicines company focused on the development of liver and respiratory rare...

155 Grant $489.58M

San Diego, United States

Biotechnology Health Care +1

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Antiva Biosciences, Inc.

30 Series E $140.35M

South San Francisco, Unit...

Biotechnology Health Care

ImageneBio

49 Series C $121.00M

San Diego, United States

Biopharma Biotechnology +1

About NovaBiotics Ltd

NovaBiotics Ltd is a clinical-stage biotechnology company that aims to address medically unmet, life-threatening, and life-limiting diseases through novel, immune-based therapies. The company's pipeline includes clinical stage antimicrobials derived from NovaBiotics' proprietary anti-infective peptide platform, as well...

Taxonomy

Drug Development, Immunology, Antimicrobials, Clinical-stage, Infectious Disease, Biologic Compounds, Cystic Fibrosis, Anti-infective Peptides, Fungal Nail Infections, Onchomycosis Treatment, Preclinical Drug Candidates, IP Portfolio, Equity Investment, Medical Innovation

Frequently Asked Questions

Companies similar to NovaBiotics Ltd include Clarametyx Biosciences, OCEAN BIOMEDICAL, Armata Pharmaceuticals, Inc., Mediar Therapeutics, Tolerx, Inc.. They work in Biotechnology and Health Care and share NovaBiotics Ltd's focus on drug development, clinical-stage and infectious disease.

Bounce Watch lists 12 companies that share NovaBiotics Ltd's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches NovaBiotics Ltd and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

NovaBiotics Ltd Profile Clarametyx Biosciences Alternatives OCEAN BIOMEDICAL Alternatives Armata Pharmaceuticals, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at NovaBiotics Ltd on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.